Replies to post #76712 on Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

I don’t know how that helps, buddy. Yes, Stendhal made a milestone payment for Aim2Cerv, but the question is whether ADXS can just drop the trial midstream without breaching the agreement with Stendhal.